Boyi Gan
Impact in
- Cancer Research top 0.05%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Pulmonary and Respiratory Medicine top 0.05%
- Ferroptosis and cancer prognosis
Papers in
-
- RNA modifications and cancer 42
- Epigenetics and DNA Methylation 18
- FOXO transcription factor regulation 7
-
- Ferroptosis and cancer prognosis 46
- Co-authors
- Li Zhuang (20 shared papers)Pranavi Koppula (18 shared papers)Guang Lei (22 shared papers)Yilei Zhang (22 shared papers)Li Zhuang (3 shared papers)Xiaoguang Liu (23 shared papers)Hyemin Lee (19 shared papers)Chao Mao (18 shared papers)
- Journals
- Nature Communications (10 papers)Cancer Research (9 papers)Protein & Cell (7 papers)Nature Cell Biology (7 papers)Journal of Biological Chemistry (6 papers)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Boyi Gan
104 papers receiving 18.4k citations
Boyi Gan's Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 7.3k
- Pulmonary and Respiratory Medicine 9.3k
- Molecular Biology 10.7k
- Aging 164
- Biochemistry 610
Countries citing papers authored by Boyi Gan
This map shows the geographic impact of Boyi Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boyi Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boyi Gan more than expected).
Fields of papers citing papers by Boyi Gan
This network shows the impact of papers produced by Boyi Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boyi Gan. The network helps show where Boyi Gan may publish in the future.
Co-authors
The 25 scholars most cited alongside Boyi Gan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy Hit paper breakdown → | 2020 | 1804 |
| 2 | Targeting ferroptosis as a vulnerability in cancer Hit paper breakdown → | 2022 | 1664 |
| 3 | DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer Hit paper breakdown → | 2021 | 1402 |
| 4 | The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression Hit paper breakdown → | 2020 | 978 |
| 5 | Energy-stress-mediated AMPK activation inhibits ferroptosis Hit paper breakdown → | 2020 | 890 |
| 6 | BAP1 links metabolic regulation of ferroptosis to tumour suppression Hit paper breakdown → | 2018 | 783 |
| 7 | Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis Hit paper breakdown → | 2023 | 714 |
| 8 | Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer Hit paper breakdown → | 2018 | 702 |
| 9 | Long noncoding RNA MALAT1 suppresses breast cancer metastasis Hit paper breakdown → | 2018 | 563 |
| 10 | mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation Hit paper breakdown → | 2021 | 562 |
| 11 | AMPK modulates Hippo pathway activity to regulate energy homeostasis Hit paper breakdown → | 2015 | 446 |
| 12 | Mitochondrial regulation of ferroptosis Hit paper breakdown → | 2021 | 425 |
| 13 | Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer Hit paper breakdown → | 2020 | 405 |
| 14 | Ferroptosis, radiotherapy, and combination therapeutic strategies Hit paper breakdown → | 2021 | 380 |
| 15 | A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers Hit paper breakdown → | 2022 | 353 |
| 16 | 2010 | 343 | |
| 17 | 2011 | 338 | |
| 18 | The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions Hit paper breakdown → | 2024 | 306 |
| 19 | 2016 | 252 | |
| 20 | 2012 | 238 |
About Boyi Gan
Boyi Gan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Epidemiology, having authored 110 papers that have together received 18.5k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (46 papers), RNA modifications and cancer (42 papers), Cancer, Lipids, and Metabolism (21 papers), Epigenetics and DNA Methylation (18 papers), Cancer, Hypoxia, and Metabolism (12 papers), Cancer-related molecular mechanisms research (11 papers), Autophagy in Disease and Therapy (10 papers) and FOXO transcription factor regulation (7 papers). The work is most often cited by research in Cancer Research (7.3k citations), Pulmonary and Respiratory Medicine (9.3k citations), Molecular Biology (10.7k citations), Aging (164 citations) and Biochemistry (610 citations). Boyi Gan has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Li Zhuang, Pranavi Koppula, Guang Lei, Yilei Zhang, Li Zhuang, Xiaoguang Liu, Hyemin Lee, Chao Mao, Yuelong Yan and Kellen Olszewski. Their work appears in journals such as Nature Communications, Cancer Research, Protein & Cell, Nature Cell Biology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.